U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. Berinert
  1. Approved Blood Products

STN:  BL 125287
Proper Name: C1 Esterase Inhibitor (Human)
Tradename: Berinert
Manufacturer: CSL Behring GmbH, License #1765
Indication:  

  • Treatment of acute abdominal or facial or laryngeal attacks of hereditary angioedema (HAE) in adult and adolescent patients.

Product Information

Supporting Documents


Related Information

Back to Top